Bioorganic & Medicinal Chemistry Letters 2006-03-15

Arylphthalazines. Part 2: 1-(Isoquinolin-5-yl)-4-arylamino phthalazines as potent inhibitors of VEGF receptors I and II.

Matthew A J Duncton, Evgueni L Piatnitski, Reeti Katoch-Rouse, Leon M Smith, Alexander S Kiselyov, Daniel L Milligan, Chris Balagtas, Wai C Wong, Joel Kawakami, Jacqueline F Doody

Index: Bioorg. Med. Chem. Lett. 16 , 1579, (2006)

Full Text: HTML

Abstract

A novel class of 1-(isoquinolin-5-yl)-4-arylamino-phthalazines is described as inhibitors of vascular endothelial growth factor receptor II (VEGFR-2). Many compounds display VEGFR-2 inhibitory activity with an IC(50) as low as 0.017 microM in an HTRF enzymatic assay. The compounds also inhibit VEGFR-1, a related tyrosine kinase.


Related Compounds

Related Articles:

Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptors.

2007-07-26

[J. Med. Chem. 50 , 3627, (2007)]

Discrimination of reactively-dyed cotton fibres with thin layer chromatography and UV microspectrophotometry.

1967-01-01

[Sci. Justice 55 , 422-30, (2015)]

Synthesis of 4-aryl-1-(4-methylpiperazin-1-yl) phthalazines by Suzuki-type cross-coupling reaction. Guery S, et al.

[Synthesis 2001(05) , 699-701, (2001)]

A simple and effective soluble polymer-bound ligand for the asymmetric dihydroxylation of olefins: DHQD-PHAL-OPEG-OMe. Kuang YQ, et al.

[Tetrahedron Lett. 42(34) , 5925-5927, (2001)]

More Articles...